Stock info Pacific Biosciences of California | Filter  Basic-Info

Stock: Pacific Biosciences of California (US broad)

Last Price 1.39 Max Price 2.63
Min Price 0.91 1 Year return -89.50
Sector Industry Subsector Support Services

Loading...

Contact info:Country: USAWebsite: www.acb.com

Sector Review Pacific Biosciences of California

Loading...
Year Turnover Total sector Market share
2019 81 460,676 0.02 %
2020 65 437,888 0.01 %
2021 115 530,323 0.02 %
2022 120 636,545 0.02 %
2023 182 656,612 0.03 %

Advice Pacific Biosciences of California

No Records Found




News Pacific Biosciences of California

No Records Found

Annual reports Pacific Biosciences of California

No Records Found


Profile Pacific Biosciences of California

Pacific Biosciences of California


Pacific Biosciences of California's core business is the biotech sector. The period from 2006 till the end of 2016 the international sector gained around 59 percent. As from 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.

The past year was a good investment year for Pacific Biosciences of California investors

Over the last 12 months (from December 2015 till December 2016), that were loss-making period for the investors in Pacific Biosciences of California, the stock lost around 64 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 77 percent. Pacific Biosciences of California's revenues between 2011 and 2015 were very volatile through the time and moved between 25,98 million dollars and 92,78 million dollars. Pacific Biosciences of California's net incomes between 2011 and 2015 were very volatile and moved between -109,39 million dollars and -31,7 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Healthy financed: not so much debt Pacific Biosciences of California

At the end of 2015 the biotech company's balance sheet was worth 131,11 million dollars. Last year the total debt of the company was 57,57 million dollars. This equals around 43,91 percent of the total balance sheet. As per the end of 2015 Pacific Biosciences of California's price/earnings-ratio equaled -19. So investors paid for 1 stock -19 times the earnings per share of 2015. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the American company's market capitalization equaled around 955,76 million dollars. At the end of 2015 the American company had around 75,61 million stocks listed.

On this page you can find all Pacific Biosciences of California's financial reports. More information about Pacific Biosciences of California can be found it's website. .


Results Pacific Biosciences of California

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Pacific Biosciences of California

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Pacific Biosciences of California

Details
2016
2017
2018
2019
2020
Price
3.80
2.64
7.40
5.14
25.94
Eps
-0.79
-0.73
-0.66
-0.49
0.14
Price/earnings-ratio
-4.81
-3.62
-11.21
-10.49
9.93
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
0.87
0.62
0.66
0.32
1.43
Market to book
0.23
0.23
0.09
0.06
1.03
Cashflow per stock
-0.70
-0.48
-0.39
-0.46
0.08
Stocks
93
116
150
153
192
Market Cap
352.17
306.97
1.111.81
787.03
267.29

Dividend Pacific Biosciences of California


Price info Pacific Biosciences of California

Date
Price
10 Mar 2026
1.39
08 Mar 2026
1.38
03 Mar 2026
1.62
24 Feb 2026
1.58
10 Feb 2026
1.84
06 Feb 2026
1.72
04 Feb 2026
2.04
28 Jan 2026
2.57
26 Jan 2026
2.58
21 Jan 2026
2.36
17 Jan 2026
2.21
13 Jan 2026
2.01
21 Dec 2025
1.84
18 Dec 2025
1.93
17 Dec 2025
2.02
16 Dec 2025
2.12
15 Dec 2025
2.12
11 Dec 2025
2.37
10 Dec 2025
2.43
09 Dec 2025
2.32
04 Dec 2025
2.43
03 Dec 2025
2.32
27 Nov 2025
2.39
26 Nov 2025
2.63
22 Nov 2025
2.22
20 Nov 2025
1.76
19 Nov 2025
1.65
18 Nov 2025
1.57
17 Nov 2025
1.61
15 Nov 2025
1.61